Patient assistance
Free help paying for cancer medications.
mendmeds tracks 17 cancer medications, with 32 active assistance programs, each linked to its official source with the date we checked it.
Browse
Every cancer medication we cover
- Calquence (acalabrutinib)Medicare options2 active programsTypically around $15,500 per month without assistance
- Ibrance (palbociclib)Medicare options2 active programsTypically around $15,000 per month without assistance
- Imbruvica (ibrutinib)Medicare options2 active programsTypically around $17,000 per month without assistance
- Jakafi (ruxolitinib)2 active programsTypically around $16,000 per month without assistance
- Jubbonti (denosumab-bbdz)1 active program
- Keytruda (pembrolizumab)2 active programs
- Lynparza (olaparib)Medicare options2 active programsTypically around $17,000 per month without assistance
- Osenvelt (denosumab-bmwo)2 active programs
- Pomalyst (pomalidomide)Medicare options2 active programsTypically around $24,000 per month without assistance
- Prolia (denosumab)2 active programs
- Revlimid (lenalidomide)Medicare options2 active programsTypically around $22,000 per month without assistance
- Stoboclo (denosumab-bmwo)2 active programs
- Tagrisso (osimertinib)Medicare options2 active programsTypically around $19,000 per month without assistance
- Verzenio (abemaciclib)Medicare options2 active programsTypically around $15,500 per month without assistance
- Wyost (denosumab-bbdz)1 active program
- Xgeva (denosumab)2 active programs
- Xtandi (enzalutamide)2 active programsTypically around $14,500 per month without assistance